|
KLHL5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.013000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.474400E-01 |
| Normal-vs-Stage2 |
2.973600E-01 |
| Normal-vs-Stage3 |
1.231570E-01 |
| Normal-vs-Stage4 |
1.331160E-01 |
| Stage1-vs-Stage2 |
3.056200E-01 |
| Stage1-vs-Stage3 |
5.514200E-02 |
| Stage1-vs-Stage4 |
9.995900E-02 |
| Stage2-vs-Stage3 |
7.070800E-01 |
| Stage2-vs-Stage4 |
6.314200E-01 |
| Stage3-vs-Stage4 |
8.632600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.616200E-01 |
| Normal-vs-AfricanAmerican |
7.450600E-01 |
| Normal-vs-Asian |
2.197200E-01 |
| Caucasian-vs-AfricanAmerican |
8.434000E-01 |
| Caucasian-vs-Asian |
4.668200E-01 |
| AfricanAmerican-vs-Asian |
4.737800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.277000E-01 |
| Normal-vs-Female |
5.200000E-01 |
| Male-vs-Female |
3.350800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.617800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.611800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.643000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.918200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.497300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.101430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.625000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.918000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.085200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.235600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.944200E-01 |
| Classical-VS-Follicular |
1.047970E-01 |
| Classical-VS-Other |
5.034400E-02 |
| Classical-VS-Normal |
7.785600E-01 |
| Tall-VS-Follicular |
6.774000E-01 |
| Tall-VS-Other |
1.900170E-01 |
| Tall-VS-Normal |
5.441800E-01 |
| Follicular-VS-Other |
2.144200E-01 |
| Follicular-VS-Normal |
1.885380E-01 |
| Other-VS-Normal |
3.436400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.991350E-01 |
| Normal-vs-N1 |
2.701600E-01 |
| N0-vs-N1 |
8.824600E-01 |
|
|
